News Finding: "Each antigen we tested eliminated 10 to 100 per cent of the leukemia," said Perreault, adding that "some of the antigens protected the mouse for its entire life, despite the reinjection of new leukemia cells.
Paper Finding: The two VNYIHRNV-immunized survivors died of leukemia within 50 days, whereas all others (immunized against TVPLNHNTL, VTPVYQHL, or VNYLHRNV) survived the rechallenge (Fig.
News Context: The results were highly encouraging. "Each antigen we tested eliminated 10 to 100 per cent of the leukemia," said Perreault, adding that "some of the antigens protected the mouse for its entire life, despite the reinjection of new leukemia cells. This suggests a long-lasting effect."
Paper Context: In contrast, the other three TSAs showed superior efficacy, with day 150 survival rates of 20% (VNYIHRNV), 30% (VTPVYQHL), and 100% (VNYLHRNV) (Fig. The two VNYIHRNV-immunized survivors died of leukemia within 50 days, whereas all others (immunized against TVPLNHNTL, VTPVYQHL, or VNYLHRNV) survived the rechallenge (Fig. We conclude that immunization against individual TSAs confers different degrees of protection against EL4 cells (0 to 100%) and that, in most cases, this protection is long-lasting.